New Studies Find Cannabis Reduces Alzheimer’s-Induced Agitation
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyAgingTHCCBDResearchMental HealthSafety Why This Matters Clinicians managing behavioral symptoms in…
German Cannabis Market Study: Rising THC, Dropping Prices
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. THCResearchIndustryPolicyPainSafetyDosing Why This Matters Clinicians prescribing cannabis in regulated markets need…
Frequent Marijuana Use Linked To Higher Stress Hormone Levels – USNews.com
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthTHCSafetyAnxietyNeurologyPolicy Why This Matters Clinicians should be aware that frequent cannabis…
Clinical Trial: THC/CBD Formulation Reduces Alzheimer’s-Induced Agitation
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyCBDTHCAgingMental HealthSafety Why This Matters Clinicians treating Alzheimer's disease patients…
Study Published in Pediatrics Finds Infrequent Cannabis Use Can Impact Adolescent …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPediatricsMental HealthSafetyTHCNeurologyAnxiety Why This Matters Clinicians caring for adolescents need this…
Daily Cannabis News Brief: Cannabidiol and Intestinal Protection
Recent evidence highlights cannabidiol antioxidant intestinal protection as a key factor in improving gut health by reducing oxidative stress and inflammation. This clinical insight from 2026 cannabis research suggests potential therapeutic applications.…
Combination of THC and CBD eased symptoms in especially frail population. #HeraldPremium
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAgingSafetyDosingPain Why This Matters Clinicians treating frail patients with multiple comorbidities now…
Cannabinoids Fall Short Across Most Psychiatric Disorders
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthResearchSafetyTHCCBDPediatricsAnxiety Why This Matters Clinicians should be aware that current evidence does…
Is VER-01 a Turning Point for Cannabis-Derived Medicines?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCSafetyNeurologyIndustryPain Why This Matters Clinicians need to understand that pharmaceutical cannabinoids…
Cannabinoids Fall Short Across Most Psychiatric Disorders
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthCBDTHCSafetyAnxietyNeurology Why This Matters Clinicians prescribing or considering cannabinoids for…